Circadian and behavioral factors of cardiovascular risk

心血管风险的昼夜节律和行为因素

• 批准号: 7114283
• 负责人: STEVEN A SHEA
• 金额: $ 49.65万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-09-15 至 2009-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7114283
• 关键词: biological clocks; biomarker; blood cell count; blood pressure; body temperature; cardiovascular disorder risk; catecholamines; circadian rhythms; clinical research; cortisol; electrocardiography; exercise; heart rate; human subject; platelet aggregation; polysomnography; posture; psychological stressor; sleep; vascular endothelium; vasodilation; wakefulness

DESCRIPTION (provided by applicant): Numerous epidemiological studies have established that there is a disproportionately high frequency of adverse cardiovascular events around 9 AM (e.g., sudden cardiac death, myocardial infarction). The mechanisms have been loosely attributed to behavioral stressors occurring at specific times of day (e.g., change in posture or activity). But, the independent role of the internal body clock (circadian pacemaker) in this day/night pattern has never been studied with appropriate techniques. Our preliminary data show a marked endogenous circadian rhythm in some markers of cardiovascular risk that may be implicated in the day/night pattern of adverse cardiovascular events. Thus, we have two Specific Aims: (1) Determine the effect upon cardiovascular risk markers of the circadian pacemaker (independent from behaviors); (2) Determine the interaction between circadian and behavioral influences upon cardiovascular risk markers (i.e., an interaction by which behavioral stressors have different effects at different circadian phases). To achieve these aims, we will utilize an intensive 12-day "Forced Desynchrony" protocol, wherein subjects' standardized behaviors and sleep occur at all phases of the circadian cycle. As this will be the first formal study in this area, we will begin by studying healthy individuals to define the normal human physiological rhythms and responses that could be implicated in the day/night pattern of cardiovascular risk. During the protocol standardized behavioral stressors include changes in posture (tilt table), activity (bicycle exercise) and sleep/wake state. The measures that can be implicated in triggering adverse cardiovascular events in vulnerable individuals, will include (i) autonomic nervous system activity (catecholamines, sympatho-vagal balance); (ii) hemodynamic factors (heart rate, blood pressure); (iii) Hemostatic factors (platelet aggregability and count); and (iv) vascular endothelial function (flow mediated vasodilatation). Based on preliminary data, we anticipate that behavioral stressors will have different effects at specific phases of the circadian cycle revealing vulnerable times for certain behaviors (likely corresponding to the peak in cardiovascular vulnerability from epidemiological studies). This project may ultimately help us to rationalize chronobiological therapies for cardiovascular diseases in terms of modification of behavior and timed pharmacological intervention.

描述（由申请人提供）：许多流行病学研究已经确定，上午9点左右不良心血管事件的频率不成比例地高（例如，心源性猝死、心肌梗死）。 这些机制被松散地归因于在一天中特定时间发生的行为应激源（例如，改变姿势或活动）。 但是，内部生物钟（昼夜节律起搏器）在这种昼夜模式中的独立作用从未用适当的技术进行过研究。 我们的初步数据显示，心血管风险的一些标志物中存在明显的内源性昼夜节律，这可能与不良心血管事件的昼夜模式有关。 因此，我们有两个具体目的：（1）确定昼夜节律起搏器对心血管风险标志物的影响（独立于行为）;（2）确定昼夜节律和行为对心血管风险标志物的影响之间的相互作用（即，行为压力源在不同昼夜节律阶段具有不同影响的相互作用）。 为了实现这些目标，我们将利用一个密集的12天的“强迫睡眠”方案，其中受试者的标准化行为和睡眠发生在昼夜节律周期的所有阶段。 由于这将是该领域的第一项正式研究，我们将开始研究健康个体，以确定可能与心血管风险的昼夜模式有关的正常人体生理节律和反应。 在方案期间，标准化的行为应激源包括姿势（倾斜台）、活动（自行车运动）和睡眠/清醒状态的变化。 可能涉及在脆弱个体中触发不良心血管事件的措施将包括（i）自主神经系统活动（儿茶酚胺、交感神经-迷走神经平衡）;（ii）血液动力学因素（心率、血压）;（iii）止血因素（血小板聚集性和计数）;和（iv）血管内皮功能（流动介导的血管舒张）。 根据初步数据，我们预计行为压力源将在昼夜节律周期的特定阶段产生不同的影响，揭示某些行为的脆弱时间（可能对应于流行病学研究中心血管脆弱性的峰值）。 这个项目可能最终帮助我们合理化心血管疾病的时间生物学治疗的行为和定时药物干预方面的修改。

项目成果

The human endogenous circadian system causes greatest platelet activation during the biological morning independent of behaviors.

• DOI: 10.1371/journal.pone.0024549
• 发表时间: 2011
• 期刊: PloS one
• 影响因子: 3.7
• 作者: Scheer FA;Michelson AD;Frelinger AL 3rd;Evoniuk H;Kelly EE;McCarthy M;Doamekpor LA;Barnard MR;Shea SA
• 通讯作者: Shea SA